My goal is to bring the best of Lincoln to each and every transaction, ensuring the topmost outcomes for our clients.
Roddy is Managing Director and Co-head of Lincoln’s U.S. Healthcare Group. He has more than 27 years of investment banking expertise in the healthcare services sector and significant transaction experience covering both buy- and sell-side mergers and acquisitions (M&A) and equity, debt and convertible financings, completing more than 260 transactions totaling over $75 billion.
Roddy has deep domain expertise in animal health, which he covers holistically across veterinary clinics, diagnostics, pharmaceuticals, IT, nutrition and distribution. Further, he has developed a strong track record in provider-based services including ambulatory surgery centers, physical therapy clinics, specialty physician practices, healthcare staffing, distribution and behavioral health.
Prior to joining Lincoln, Roddy worked as a Managing Director in Piper Sandler’s (formerly Piper Jaffray) healthcare investment banking group. Previously, he worked at UBS and Citi.
Roddy earned a bachelor’s degree from Duke University.
Recent Transactions in Healthcare
Lincoln International is pleased to announce that it has advised The Vet Connection on its sale to Pets at Home Group PLC (LSE:PETS)
Lincoln International is pleased to announce that LT Smile Corporation (Benevis) has been acquired under Section 363 of the United States Bankruptcy Code by New Mountain Capital
Lincoln International is pleased to announce that it served as the exclusive financial advisor to Alva-Amco Pharmacal in its sale to Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)
Lincoln International is pleased to announce that Choice Health Insurance, LLC, a fully integrated consumer acquisition platform specializing in the high-growth, Medicare Advantage marketplace, has been acquired by Alight Solutions, a portfolio company of Blackstone
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries
Lincoln International is pleased to announce that it has advised Doppel Farmaceutici, a portfolio company of Trilantic Europe, on the financing of its acquisition of Dietopack
Lincoln International is pleased to announce that The Araz Group, Inc. (d/b/a HealthEZ) has received an investment from Abry Partners LP
Lincoln International advised Gruppo Sapio on the acquisition of a majority stake in Homeperf from Parquest Capital; BNP Paribas Développement and Arkea Capital will reinvest in the business alongside Sapio
Perspectives by Roderick O’Neill
Q&A with Lincoln’s Newest Healthcare Managing Directors: Unpacking Market Dynamics & Deal-making for the Months Ahead
In summer 2020, Lincoln International welcomed three healthcare Managing Directors – Dirk-Oliver Löffler, in Germany, Roddy O’Neill, in New York, and Emily Wildes, in Chicago. Their arrival complements a global team of […]